Wednesday, June 12, 2013
8:30 a.m. – 12:30 p.m.
Boston Convention & Exhibition Center (BCEC)
Boston, MA  USA

This session is open to all registered meeting delegates and is included with your registration. No pre-registration is required.


Preclinical Advances in Stem Cell Research- Technologies Accelerating Clinical Translation



Presented by PerkinElmer






The field of stem cell research has seen unprecedented growth within the last decade as researchers attempt to better understand stem cell biology and its therapeutic potential. High Content Screening and optical imaging have emerged as vital tools for stem cell research as the most sensitive approach to assess stem cell homing, differentiation, and therapeutic potential. Our range of in vivo optical instruments, high content screening systems and innovative cell labeling agents like VivoTrack™ 680 are tremendous assets in understanding the complexities of stem cell behavior in vivo. This symposium will explore stem cell in vivo research and recent advances in optical and multimodal in vivo imaging technologies and applications.

What Will Be Covered

  • Discuss stem cell labeling strategies for in vivo non-invasive detection
  • Imaging as a tool to track distribution and engraftment of stem cells in vivo
  • Monitoring  therapeutic efficacy and safety readouts of stem cell therapy
  • Role of High content screening in Stem cell research
  • Advances in optical and multimodal imaging technologies 

Agenda

8:30 – 9:15 am 

Spinal Muscular Atrophy – From Screen to Target 
Nina Makhortova, Ph.D., Harvard University Department of Stem Cell and Regenerative Biology

9:15 – 10:00 am

Bioluminescence imaging and MRI: Complementary Imaging Modalities for Tracking Stem Cells Transplanted into the CNS 
Piotr Walczak, MD/Ph.D., Associate Professor, Division of MR Research, The Russell H. Morgan Department of Radiology and Radiological Science 

10:00 –10:45 am     

In Vivo Optical Imaging: Shining a Light on Stem Cell Research. 
Vivek R. Shinde Patil, Ph.D., Director, Technical Applications, PerkinElmer

10:45 – 11:30 am                     

Utilization of stem cell technologies in drug development.
Hirdesh Uppal, Ph.D., Scientist, Genentech, A Member of the Roche Group. 

 11:30 – 12:15 pm

A novel model for characterizing the hematopoietic and metastatic niche formation in bone
Rosalynd Upton, Stanford University School of Medicine, Institute of Stem Cell Biology and Regenerative Medicine